Children's National Research Institute

Evaluation of the Safety and Efficacy of Mifamurtide Versus Standard Treatment With Sorafenib in Patients With High-risk Osteosarcoma

Collaborator, Phase 2, Recruiting, 2026, 40 people, 26 Aug 2026, clinicaltrials.gov

NCT07017816

Early phase 1, Recruiting, 2025, 18 people, 12 Jun 2025, clinicaltrials.gov

NCT06907173

Collaborator, Phase 3, Recruiting, 2026, 770 people, 2 Apr 2025, clinicaltrials.gov

A Basket Clinical Study to Assess Glycerol Tributyrate in Patients With Mitochondrial Encephalopathy, Lactic Acidosis, Stroke-like Episodes (MELAS) or Leber's Hereditary Optic Neuropathy-Plus (LHON-Plus)

Collaborator, Phase 1/2, Not yet recruiting, 2027, 24 people, 24 Jan 2025, clinicaltrials.gov

NCT06429982

Phase 1, Recruiting, 2024, 50 people, 28 May 2024, clinicaltrials.gov

NCT06358638

Phase 2, Recruiting, 2024, 12 people, 10 Apr 2024, clinicaltrials.gov

NCT05305898

Phase 3, Status unknown, 2022, 2,000 people, 31 Mar 2022, clinicaltrials.gov

NCT05271162

Phase 3, Active, not recruiting, 2023, 220 people, 8 Mar 2022, clinicaltrials.gov

NCT04731974

Phase 2, Status unknown, 2023, 254 people, 1 Feb 2021, clinicaltrials.gov

NCT04695106

Collaborator, Phase 4, Recruiting, 2021, 1,194 people, 5 Jan 2021, clinicaltrials.gov

NCT03936894

Phase 1/2, Status unknown, 2019, 3 people, 3 May 2019, clinicaltrials.gov

NCT03644953

Phase 2, Completed, 2018, 14 people, 23 Aug 2018, clinicaltrials.gov

NCT02960659

Collaborator, Phase 1/2, Completed, 2017, 24 people, 10 Nov 2016, clinicaltrials.gov

NCT02165007

Collaborator, Phase 1, Completed, 2015, 7 people, 17 Jun 2014, clinicaltrials.gov

NCT02090296

Phase 2, Withdrawn, 2014, 0 people, 18 Mar 2014, clinicaltrials.gov

NCT01960075

Collaborator, Phase 3, Completed, 2015, 478 people, 10 Oct 2013, clinicaltrials.gov

NCT01549418

Phase 4, Status unknown, 2012, 760 people, 9 Mar 2012, clinicaltrials.gov

NCT01425307

Collaborator, Phase 3, Terminated, 2011, 159 people, 30 Aug 2011, clinicaltrials.gov

NCT01158651

Collaborator, Phase 2, Completed, 2010, 23 people, 8 Jul 2010, clinicaltrials.gov

NCT00901849

Collaborator, Phase 1, Completed, 2007, 21 people, 14 May 2009, clinicaltrials.gov